Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ka Kit Wong

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Clinical Nuclear Medicine|January 31, 2016
Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic ReviewKa Kit Wong, Barbra S Miller, Benjamin L Viglianti, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2025
<sup>177</sup>Lu-PSMA-617 Single-Photon Emission Computed Tomography/Computed Tomography Dosimetry and Radiobiological Models Demonstrate Decreasing Tumor-to-Kidney Dose Ratio With Successive CyclesKellen J Fitzpatrick, Justin K Mikell, Molly E Roseland, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Synthesis and Evaluation of <sup>11</sup>C- and <sup>18</sup>F-Labeled SOAT1 Inhibitors as Macrophage Foam Cell Imaging AgentsJames R Hill, Xia Shao, Jay S Wright, et al.
Clinical Nuclear Medicine|November 14, 2025
Posology for 177Lu-DOTATATE Therapy in Neuroendocrine Tumor: Effectiveness of Dose Reduction and Cycle Delay for Improving Therapy TolerabilityIvan E Wang, Jasmine Patterson, Azadeh Akhavanallaf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After <sup>177</sup>Lu-Peptide Receptor Radionuclide TherapyYuni K Dewaraja, David M Mirando, Avery B Peterson, et al.
Molecular Imaging and Biology|October 17, 2020
Effect of Propranolol on 18F-Fluorodeoxyglucose Uptake in Brown Adipose Tissue in Children and Young Adults with Neoplastic DiseasesSamuel L Brady, Ka Kit Wong, Mikhail Doubrovin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2019
Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imagingBenjamin L Viglianti, Daniel J Wale, Tianwen Ma, et al.
Oral Oncology|January 7, 2014
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Matthew H Stenmark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter DataAzadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Clinical Nuclear Medicine|January 31, 2016
Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic ReviewKa Kit Wong, Barbra S Miller, Benjamin L Viglianti, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2025
<sup>177</sup>Lu-PSMA-617 Single-Photon Emission Computed Tomography/Computed Tomography Dosimetry and Radiobiological Models Demonstrate Decreasing Tumor-to-Kidney Dose Ratio With Successive CyclesKellen J Fitzpatrick, Justin K Mikell, Molly E Roseland, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Synthesis and Evaluation of <sup>11</sup>C- and <sup>18</sup>F-Labeled SOAT1 Inhibitors as Macrophage Foam Cell Imaging AgentsJames R Hill, Xia Shao, Jay S Wright, et al.
Clinical Nuclear Medicine|November 14, 2025
Posology for 177Lu-DOTATATE Therapy in Neuroendocrine Tumor: Effectiveness of Dose Reduction and Cycle Delay for Improving Therapy TolerabilityIvan E Wang, Jasmine Patterson, Azadeh Akhavanallaf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After <sup>177</sup>Lu-Peptide Receptor Radionuclide TherapyYuni K Dewaraja, David M Mirando, Avery B Peterson, et al.
Molecular Imaging and Biology|October 17, 2020
Effect of Propranolol on 18F-Fluorodeoxyglucose Uptake in Brown Adipose Tissue in Children and Young Adults with Neoplastic DiseasesSamuel L Brady, Ka Kit Wong, Mikhail Doubrovin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2019
Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imagingBenjamin L Viglianti, Daniel J Wale, Tianwen Ma, et al.
Oral Oncology|January 7, 2014
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Matthew H Stenmark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter DataAzadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
Pageof 11